MEET the EXCiSiON TEAM

Excision BioTherapeutics has assembled an exceptional team of molecular biology regulatory management and clinical experts with concentrations in building companies in the life sciences sector.

 

Board of Directors

Management

Thomas Malcolm, Ph.D.

President & CEO


Kamel Khalili, Ph.D.

Principal Scientific Advisor


Daniel Dornbusch, MBA

Sr. VP Business Development


Neal Kaplan, CFA

Vice President, Operations



Scientific Advisors

Kamel Khalili, Ph.D.

Principal Scientific Advisor
(All Viruses)

Jennifer Gordon Ph.D.

Temple University
Lewis Katz School of Medicine
(All Viruses)

Joseph Berger, M.D.

Perelman School of Medicine
University of Pennsylvania
(JC Virus & PML)

Ivan Sadowski, Ph.D.

University of British Columbia
(Human Immunodeficiency Virus-1)
 

David Margolis, M.D.

​University of North Carolina
Chapel Hill
(Human Immunodeficiency Virus-1)

Pasquale Ferrante, M.D.

​University of Milan
(JC Virus & PML)

Kimberly Wiegand Ph.D.

​University of British Columbia

Joseph Bondy-Denomy

​University of California
San Francisco
(CRISPR Inhibitors)